Engineering perspective on transcatheter aortic valve implantation

Interventional Cardiology (London)

Volumn 5, Issue 1, 2013, Pages 53-70

  Tseng, Elaine E ^a,b   Wisneski, Andrew ^a,b   Azadani, Ali N ^a,b   Ge, Liang ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

circulation; computational and experimental techniques; heart valve; hemodynamics; transcatheter aortic valve

Indexed keywords

AORTA ROOT; AORTA STENOSIS; AORTA VALVE PROSTHESIS; BIOENGINEERING; BIOPROSTHESIS; CARDIAC IMAGING; COMPUTATIONAL FLUID DYNAMICS; CORONARY STENT; ENDOVASCULAR SURGERY; EQUIPMENT DESIGN; FLUOROSCOPY; FORCE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE OUTFLOW TRACT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MEASUREMENT; MINIMALLY INVASIVE SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SYSTOLE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VELOCITY;

EID: 84874024731     PISSN: 17555302     EISSN: 17555310     Source Type: Journal    
DOI: 10.2217/ica.12.73     Document Type: Review

References (95)

1. Leon MB, Smith CR, Mack M et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Engl. J. Med. 363(17), 1597-1607 (2010).
2. Smith CR, Leon MB, Mack MJ et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N. Engl. J. Med. 364(23), 2187-2198 (2011).
3. Kodali SK, Williams MR, Smith CR et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N. Engl. J. Med. 366(18), 1686-1695 (2012).
4. Makkar RR, Fontana GP, Jilaihawi H et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N. Engl. J. Med. 366(18), 1696-1704 (2012).
5. Cribier A, Eltchaninoff H, Bash A et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106(24), 3006-3008 (2002). (Pubitemid 35440280)
6. Webb JG, Wood DA. Current status of transcatheter aortic valve replacement. J. Am. Coll. Cardiol. 60(6), 483-492 (2012).
7. Thomas M, Schymik G, Walther T et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 124(4), 425-433 (2011).
8. Ussia GP, Barbanti M, Petronio AS et al. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. Eur. Heart J. 33(8), 969-976 (2012).
9. Rodes-Cabau J. Transcatheter aortic valve implantation: current and future approaches. Nat. Rev. Cardiol. 9(1), 15-29 (2011).
10. Walther T, Kempfert J, Mohr FW. Transcatheter aortic valve implantation: surgical perspectives. Arch. Cardiovasc. Dis. 105(3), 174-180 (2012).
11. Gilard M, Eltchaninoff H, Iung B et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N. Engl. J. Med. 366(18), 1705-1715 (2012).
12. Piazza N, Grube E, Gerckens U et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 4(2), 242-249 (2008).
13. Thomas M, Schymik G, Walther T et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 122(1), 62-69 (2010).
14. Zahn R, Gerckens U, Grube E et al. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur. Heart J. 32(2), 198-204 (2011).
15. Bach DS. Prevalence and characteristics of unoperated patients with severe aortic stenosis. J. Heart Valve Dis. 20(3), 284-291 (2011).
16. Malaisrie SC, Tuday E, Lapin B et al. Transcatheter aortic valve implantation decreases the rate of unoperated aortic stenosis. Eur. J. Cardiothorac. Surg. 40(1), 43-48 (2011).
17. Brown JM, O'brien SM, Wu C, Sikora JA, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J. Thorac. Cardiovasc. Surg. 137(1), 82-90 (2009).
18. Sawaya F, Liff D, Stewart J, Lerakis S, Babaliaros V. Aortic stenosis: a contemporary review. Am. J. Med. Sci. 343(6), 490-496 (2012).
19. Thourani VH, Myung R, Kilgo P et al. Long-term outcomes after isolated aortic valve replacement in octogenarians: a modern perspective. Ann. Thorac. Surg. 86(5), 1458-1464; discussion 1464-1465 (2008).
20. O'Brien SM, Shahian DM, Filardo G et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2-isolated valve surgery. Ann. Thorac. Surg. 88(Suppl. 1), S23-S42 (2009).
21. Tjang YS, van Hees Y, Korfer R, Grobbee DE, van der Heijden GJ. Predictors of mortality after aortic valve replacement. Eur. J. Cardiothorac. Surg. 32(3), 469-474 (2007). (Pubitemid 47223739)
22. Subramanian S, Rastan AJ, Holzhey D et al. Conventional aortic valve replacement in transcatheter aortic valve implantation candidates: a 5-year experience. Ann. Thorac. Surg. 94(3), 726-729; discussion 729-730 (2012).
23. Vahanian A, Alfieri O, Andreotti F et al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur. J. Cardiothorac. Surg. 42(4), S1-S44 (2012).
24. Holmes DR Jr, Mack MJ, Kaul S et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J. Am. Coll. Cardiol. 59(13), 1200-1254 (2012).
25. Tommaso CL, Bolman RM 3rd, Feldman T et al. Multisociety (AATS, ACCF, SCAI, and STS) expert consensus statement: operator and institutional requirements for transcatheter valve repair and replacement, part 1: transcatheter aortic valve replacement. J. Thorac. Cardiovasc. Surg. 143(6), 1254-1263 (2012).
26. Schofer J, Schluter M, Treede H et al. Retrograde transarterial implantation of a nonmetallic aortic valve prosthesis in high-surgical-risk patients with severe aortic stenosis: a first-in-man feasibility and safety study. Circ. Cardiovasc. Interv. 1(2), 126-133 (2008).
27. Treede H, Tubler T, Reichenspurner H et al. Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: the Direct Flow Medical aortic valve. J. Thorac. Cardiovasc. Surg. 140(4), 897-903 (2010).
28. Gaia DF, Palma JH, Souza JA et al. Off-pump transapical balloon-expandable aortic valve endoprosthesis implantation. Rev. Bras. Cir. Cardiovasc. 24(2), 233-238 (2009).
29. Gaia DF, Palma JH, Ferreira CB et al. Transapical aortic valve implantation: results of a Brazilian prosthesis. Rev. Bras. Cir. Cardiovasc. 25(3), 293-302 (2010).
30. Kempfert J, Rastan AJ, Beyersdorf F et al. Trans-apical aortic valve implantation using a new self-expandable bioprosthesis: initial outcomes. Eur. J. Cardiothorac. Surg. 40(5), 1114-1119 (2011).
31. Kempfert J, Rastan AJ, Mohr FW, Walther T. A new self-expanding transcatheter aortic valve for transapical implantation-first in man implantation of the JenaValve. Eur. J. Cardiothorac. Surg. 40(3), 761-763 (2011).
32. Buellesfeld L, Gerckens U, Grube E. Percutaneous implantation of the first repositionable aortic valve prosthesis in a patient with severe aortic stenosis. Catheter Cardiovasc. Interv. 71(5), 579-584 (2008). (Pubitemid 351550389)
33. Falk V, Schwammenthal EE, Kempfert J et al. New anatomically oriented transapical aortic valve implantation. Ann. Thorac. Surg. 87(3), 925-926 (2009).
34. Falk V, Walther T, Schwammenthal E et al. Transapical aortic valve implantation with a self-expanding anatomically oriented valve. Eur. Heart J. 32(7), 878-887 (2011).
35. Del Valle-Fernandez R, Martinez CA, Ruiz CE. Transcatheter aortic valve implantation. Cardiol. Clin. 28(1), 155-168 (2010).
36. Krishnaswamy A, Tuzcu EM, Kapadia SR. Update on transcatheter aortic valve implantation. Curr. Cardiol. Rep. 12(5), 393-403 (2010).
37. Grube E, Buellesfeld L, Mueller R et al. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system. Circ. Cardiovasc. Interv. 1(3), 167-175 (2008).
38. Helton TJ, Kapadia SR, Tuzcu EM. Clinical trial experience with transcatheter aortic valve insertion. Int. J. Cardiovasc. Imaging (2011).
39. Stuhle S, Wendt D, Houl G et al. In vitro investigation of the hemodynamics of the Edwards Sapien transcatheter heart valve. J. Heart Valve Dis. 20(1), 53-63 (2011).
40. Markl M, Mikati I, Carr J, Mccarthy P, Malaisrie SC. Three-dimensional blood flow alterations after transcatheter aortic valve implantation. Circulation 125(15), e573-e575 (2012).
41. Dwyer HA, Matthews PB, Azadani A, Ge L, Guy TS, Tseng EE. Migration forces of transcatheter aortic valves in patients with noncalcific aortic insufficiency. J. Thorac. Cardiovasc. Surg. 138(5), 1227-1233 (2009).
42. Dwyer HA, Matthews PB, Azadani A et al. Computational fluid dynamics simulation of transcatheter aortic valve degeneration. Interact. Cardiovasc. Thorac. Surg. 9(2), 301-308 (2009).
43. Tzamtzis S, Viquerat J, Yap J, Mullen MJ, Burriesci G. Numerical analysis of the radial force produced by the Medtronic-CoreValve and Edwards-SAPIEN after transcatheter aortic valve implantation (TAVI). Med. Engl. Phys. doi:10.1016/j.medengphy.2012.04.009 (2012) (Epub ahead of print).
44. Al Ali AM, Altwegg L, Horlick EM et al. Prevention and management of transcatheter balloon-expandable aortic valve malposition. Catheter Cardiovasc. Interv. 72(4), 573-578 (2008).
45. Geisbusch S, Bleiziffer S, Mazzitelli D, Ruge H, Bauernschmitt R, Lange R. Incidence and management of CoreValve dislocation during transcatheter aortic valve implantation. Circ. Cardiovasc. Interv. 3(6), 531-536 (2010).
46. Pang PY, Chiam PT, Chua YL, Sin YK. A survivor of late prosthesis migration and rotation following percutaneous transcatheter aortic valve implantation. Eur. J. Cardiothorac. Surg. 41(5), 1195-1196 (2012).
47. Tay EL, Gurvitch R, Wijeysinghe N et al. Outcome of patients after transcatheter aortic valve embolization. JACC Cardiovasc. Interv. 4(2), 228-234 (2011).
48. Ussia GP, Barbanti M, Imme S et al. Management of implant failure during transcatheter aortic valve implantation. Catheter Cardiovasc. Interv. 76(3), 440-449 (2010).
49. Ussia GP, Barbanti M, Sarkar K et al. Transcatheter aortic bioprosthesis dislocation: technical aspects and midterm follow-up. EuroIntervention 7(11), 1285-1292 (2012).
50. Clavel MA, Dumont E, Pibarot P et al. Severe valvular regurgitation and late prosthesis embolization after percutaneous aortic valve implantation. Ann. Thorac. Surg. 87(2), 618-621 (2009).
51. Seipelt RG, Hanekop G, Schillinger W. Migration of a transcatheter aortic valve in the left ventricular outflow tract. Heart 96(23), 1949-1950 (2010).
52. Maroto LC, Rodriguez JE, Cobiella J, Silva J. Delayed dislocation of a transapically implanted aortic bioprosthesis. Eur. J. Cardiothorac. Surg. 36(5), 935-937 (2009).
53. Ussia GP, Barbanti M, Tamburino C. Management of percutaneous self-expanding bioprosthesis migration. Clin. Res. Cardiol. 99(10), 673-676 (2010).
54. Wang Q, Sirois E, Sun W. Patient-specific modeling of biomechanical interaction in transcatheter aortic valve deployment. J. Biomech. 45(11), 1965-1971 (2012).
55. Capelli C, Bosi GM, Cerri E et al. Patient-specific simulations of transcatheter aortic valve stent implantation. Med. Biol. Eng. Comput. 50(2), 183-192 (2012).
56. Vesely I. The evolution of bioprosthetic heart valve design and its impact on durability. Cardiovasc. Pathol. 12(5), 277-286 (2003). (Pubitemid 37162712)
57. Li K, Sun W. Simulated thin pericardial bioprosthetic valve leaflet deformation under static pressure-only loading conditions: implications for percutaneous valves. Ann. Biomed. Eng. 38(8), 2690-2701 (2010).
58. Kiefer P, Gruenwald F, Kempfert J et al. Crimping may affect the durability of transcatheter valves: an experimental analysis. Ann. Thorac. Surg. 92(1), 155-160 (2011).
59. de Buhr W, Pfeifer S, Slotta-Huspenina J, Wintermantel E, Lutter G, Goetz WA. Impairment of pericardial leaflet structure from balloon-expanded valved stents. J. Thorac. Cardiovasc. Surg. 143(6), 1417-1421 (2012).
60. Heinisch PP, Richter O, Schunke M, Quaden RB. Transcatheter valve implantation: damage to the human aorta after valved stent delivery system exposure-an in vitro study. Interact. Cardiovasc. Thorac. Surg. 15(3), 352-356 (2012).
61. Zegdi R, Ciobotaru V, Noghin M et al. Is it reasonable to treat all calcified stenotic aortic valves with a valved stent? Results from a human anatomic study in adults. J. Am. Coll. Cardiol. 51(5), 579-584 (2008).
62. Wood DA, Tops LF, Mayo JR et al. Role of multislice computed tomography in transcatheter aortic valve replacement. Am. J. Cardiol. 103(9), 1295-1301 (2009).
63. Azadani AN, Jaussaud N, Matthews PB et al. Aortic valve-in-valve implantation: impact of transcatheter-bioprosthesis size mismatch. J. Heart Valve Dis. 18(4), 367-373 (2009).
64. Ng AC, Delgado V, Van Der Kley F et al. Comparison of aortic root dimensions and geometries before and after transcatheter aortic valve implantation by 2-and 3-dimensional transesophageal echocardiography and multislice computed tomography. Circ. Cardiovasc. Imaging 3(1), 94-102 (2010).
65. Kempfert J, Van Linden A, Lehmkuhl L et al. Aortic annulus sizing: echocardiographic vs. computed tomography derived measurements in comparison with direct surgical sizing. Eur. J. Cardiothorac. Surg. 42(4), 627-633 (2012).
66. Jilaihawi H, Kashif M, Fontana G et al. Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation. J. Am. Coll. Cardiol. 59(14), 1275-1286 (2012).
67. Sirois E, Wang, Q, Sun W. Fluid Simulation of a transcatheter aortic valve deployment into a patient-specific aortic root. Cardiovasc. Eng. Technol. 2(3), 186-195 (2011).
68. Schultz CJ, Weustink A, Piazza N et al. Geometry and degree of apposition of the CoreValve ReValving system with multislice computed tomography after implantation in patients with aortic stenosis. J. Am. Coll. Cardiol. 54(10), 911-918 (2009).
69. Zegdi R, Lecuyer L, Achouh P et al. Increased radial force improves stent deployment in tricuspid but not in bicuspid stenotic native aortic valves. Ann. Thorac. Surg. 89(3), 768-772 (2010).
70. Caudron J, Fares J, Hauville C et al. Evaluation of multislice computed tomography early after transcatheter aortic valve implantation with the Edwards SAPIEN bioprosthesis. Am. J. Cardiol. 108(6), 873-881 (2011).
71. Willson A, Webb J. Transcatheter treatment approaches for aortic valve disease. Int. J. Cardiovasc. Imaging 27(8), 1123-1132 (2012).
72. Allam B, Zegdi R, Blanchard D, Cholley B, Fabiani JN, Lafont A. Transfemorally or transapically deployed Sapien Edwards bioprosthesis is always deformed. J. Interv. Cardiol. 25(1), 53-61 (2012).
73. Zegdi R, Blanchard D, Achouh P et al. Deployed Edwards SAPIEN prosthesis is always deformed. J. Thorac. Cardiovasc. Surg. 140(3), e54-56 (2012).
74. Sun W, Li K, Sirois E. Simulated elliptical bioprosthetic valve deformation: implications for asymmetric transcatheter valve deployment. J. Biomech. 43(16), 3085-3090 (2010).
75. Young E, Chen JF, Dong O, Gao S, Massiello A, Fukamachi K. Transcatheter heart valve with variable geometric configuration: in vitro evaluation. Artif. Organs 35(12), 1151-1159 (2011).
76. Sherif MA, Abdel-Wahab M, Stocker B et al. Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis. J. Am. Coll. Cardiol. 56(20), 1623-1629 (2010).
77. Abdel-Wahab M, Zahn R, Horack M et al. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart 97(11), 899-906 (2011).
78. Clavel MA, Webb JG, Pibarot P et al. Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. J. Am. Coll. Cardiol. 53(20), 1883-1891 (2009).
79. Walther T, Falk V. Hemodynamic evaluation of heart valve prostheses paradigm shift for transcatheter valves? J. Am. Coll. Cardiol. 53(20), 1892-1893 (2009).
80. Akins CW, Travis B, Yoganathan AP. Energy loss for evaluating heart valve performance. J. Thorac. Cardiovasc. Surg. 136(4), 820-833 (2008).
81. Azadani AN, Jaussaud N, Matthews PB et al. Energy loss due to paravalvular leak with transcatheter aortic valve implantation. Ann. Thorac. Surg. 88(6), 1857-1863 (2009).
82. Heinrich RS, Fontaine AA, Grimes RY et al. Experimental analysis of fluid mechanical energy losses in aortic valve stenosis: importance of pressure recovery. Ann. Biomed. Eng. 24(6), 685-694 (1996).
83. Azadani AN, Jaussaud N, Matthews PB, Ge L, Chuter TA, Tseng EE. Transcatheter aortic valves inadequately relieve stenosis in small degenerated bioprostheses. Interact. Cardiovasc. Thorac. Surg. 11(1), 70-77 (2010).
84. Azadani AN, Tseng EE. Transcatheter heart valves for failing bioprostheses: state-of-the-art review of valve-in-valve implantation. Circ. Cardiovasc. Interv. 4(6), 621-628 (2011).
85. Azadani AN, Tseng EE. Transcatheter valve-in-valve implantation for failing bioprosthetic valves. Future Cardiol. 6(6), 811-831 (2010).
86. Azadani AN, Jaussaud N, Ge L, Chitsaz S, Chuter TA, Tseng EE. Valve-in-valve hemodynamics of 20-mm transcatheter aortic valves in small bioprostheses. Ann. Thorac. Surg. 92(2), 548-555 (2011).
87. Binder RK, Wood D, Webb JG, Cheung A. First-in-human valve-in-valve implantation of a 20mm balloon expandable transcatheter heart valve. Catheter Cardiovasc. Interv. doi:10.1002/ccd.24574 (2012) (Epub ahead of print).
88. Azadani AN, Jaussaud N, Matthews PB et al. Valve-in-valve implantation using a novel supravalvular transcatheter aortic valve: proof of concept. Ann. Thorac. Surg. 88(6), 1864-1869 (2009).
89. Grbic S, Ionasec R, Wang Y et al. Model-based fusion of multi-modal volumetric images: application to transcatheter valve procedures. Med. Image Comput. Comput. Assist. Interv. 14(Pt 1), 219-226 (2011).
90. Karar ME, John M, Holzhey D, Falk V, Mohr FW, Burger O. Model-updated image-guided minimally invasive off-pump transcatheter aortic valve implantation. Med. Image Comput. Comput. Assist. Interv. 14(Pt 1), 275-282 (2011).
91. Schmauss D, Schmitz C, Bigdeli AK et al. Three-dimensional printing of models for preoperative planning and simulation of transcatheter valve replacement. Ann. Thorac. Surg. 93(2), e31-e33 (2012).
92. Kahlert P, Eggebrecht H, Plicht B et al. Towards real-time cardiovascular magnetic resonance-guided transarterial aortic valve implantation: in vitro evaluation and modification of existing devices. J. Cardiovasc. Magn. Reson. 12, 58 (2010).
93. Kahlert P, Parohl N, Albert J et al. Towards real-time cardiovascular magnetic resonance guided transarterial CoreValve implantation: in vivo evaluation in swine. J. Cardiovasc. Magn. Reson. 14, 21 (2012).
94. Kahlert P, Parohl N, Albert J et al. Real-time magnetic resonance imaging-guided transarterial aortic valve implantation: in vivo evaluation in swine. J. Am. Coll. Cardiol. 59(2), 192-193 (2012).
95. Gotzmann M, Korten M, Bojara W et al. Long-term outcome of patients with moderate and severe prosthetic aortic valve regurgitation after transcatheter aortic valve implantation. Am. J. Cardiol. 110(10), 1500-1506 (2012).